SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
208 hedge funds and large institutions have $1.65B invested in Sage Therapeutics in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 61 increasing their positions, 71 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
208
Holders Change
-2
Holders Change %
-0.95%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
38
Increased
61
Reduced
71
Closed
36
Calls
$19.2M
Puts
$12.5M
Net Calls
+$6.67M
Net Calls Change
+$3.46M
Top Buyers
| 1 |
1
BlackRock
New York
|
$137M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$52.2M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$40.7M |
| 4 |
4
Goldman Sachs
New York
|
$35.7M |
| 5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$21.1M |
